Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART.
about
Creation of a Long-Acting Nanoformulated 2',3'-Dideoxy-3'-ThiacytidineEffectiveness and safety of an abacavir/lamivudine + rilpivirine regimen for the treatment of HIV-1 infection in naive patients.The treatment outcomes of antiretroviral substitutions in routine clinical settings in Asia; data from the TREAT Asia HIV Observational Database (TAHOD).MDR1 and BCRP Transporter-Mediated Drug-Drug Interaction between Rilpivirine and Abacavir and Effect on Intestinal Absorption.Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral load.
P2860
Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Efficacy and safety of switchi ...... IV-infected patients on HAART.
@en
type
label
Efficacy and safety of switchi ...... IV-infected patients on HAART.
@en
prefLabel
Efficacy and safety of switchi ...... IV-infected patients on HAART.
@en
P2093
P2860
P1476
Efficacy and safety of switchi ...... HIV-infected patients on HAART
@en
P2093
I A Pérez-Hernández
I Pérez-Camacho
J Hernández-Quero
J M Romero
M A Martínez
M L Mayorga
R Palacios
P2860
P2888
P304
P356
10.1007/S10096-016-2602-3
P577
2016-02-15T00:00:00Z
P6179
1043226001